Speakers
Gary R. Burleson, PhD
CEO/President
Burleson Research Technologies, Inc.
Morrisville, NC
Susan Elmore, MS, DVM, DACVP
NTP Pathologist/Staff Scientist
Cellular and Molecular Pathology Branch (formerly LEP)
National Institute of Environmental Health Sciences
Julie Foley, BS
Special Techniques Group Leader
Cellular and Molecular Pathology Branch (formerly LEP)
National Institute of Environmental Health Sciences
Virginia L. Godfrey, DVM, PhD, DACVP
Professor of Pathology, Division of Laboratory Animal Medicine
University of North Carolina
Chapel Hill, NC
Laura P. Hale, M.D. Ph.D.
Associate Professor of Pathology
Duke University Medical Center
Durham, NC
Holly L. Jordan, DVM, PhD, DACVP
Director of Clinical Pathology
GlaxoSmithKline, Safety Assessment
RTP, NC
Holly Kolenda-Roberts, DVM, PhD, DACVP
Pathologist
Experimental Pathology Laboratories, Inc.
RTP, NC
Dr. C.Frieke Kuper
TNO (Netherlands Organization of Applied Scientific Research) Quality of Life
Department of Toxicology and Applied Pharmacology
Zeist, the Netherlands
John D. Lich, PhD
Research Assistant Professor
Department of Microbiology and Immunology
University of North Carolina-Chapel Hill
George Parker, DVM, PhD, DACVP, DABT
Chief Pathologist
WIL-Biotechnics
Hillsborough, NC
Richard A. Peterson II, DVM, PhD, DACVP
Director, Molecular and Ultrastructural Pathology
GlaxoSmithKline, Safety Assessment
RTP, NC
Jerold E. Rehg, DVM, DACVP
Head, Veterinary Pathology
Pathology Department
St. Jude Children's Research Hospital
Memphis, TN
John P. Sundberg, DVM, PhD, DACVP
The Jackson Laboratory
Bar Harbor, ME
Henry G. Wall, DVM, PhD, DACVP
Manager, Commercial Pathology Group
Experimental Pathology Laboratories, Inc.
RTP, NC
Jerrold M. Ward, DVM, PhD, DACVP
Veterinary Pathologist
Global Vet Pathology
Kimber L. White Jr., PhD
Professor, Department of Pharmacology and Toxicology
Virginia Commonwealth University
Richmond, VA
